Medicines update

NSAID labelling review

The TGA has announced it will be reviewing product information and labelling for non-steroidal anti-inflammatory drugs.

The review will include diclofenac, naproxen, ibuprofen, celecoxib, etoricoxib, indomethacin, meloxicam and piroxicam.

These changes follow from a review of the cardiovascular risks associated with the use of these medicines and a full safety review of diclofenac.

While use